Eprosartan Impurity 2 | CAS 1794883-53-6 - Request Quote
Eprosartan Impurity 2
| SZ CAT No: | SZ-E017012 |
| CAS No | 1794883-53-6 |
| Mol.F. | C19H20N2O6 |
| Mol.Wt. | 372.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Eprosartan Impurity 2 is chemically 2-((2-Butyl-1-(4-carboxybenzyl)-1H-imidazol-5-yl)methylene)malonic acid. Eprosartan Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Eprosartan Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Eprosartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1794883-53-6
Purchase 1794883-53-6
Order 1794883-53-6
Enquire 1794883-53-6
price of 1794883-53-6
1794883-53-6 Supplier
1794883-53-6 Manufacturer
1794883-53-6 Exporter
buy high quality Eprosartan Impurity 2
Purchase Eprosartan Impurity 2
Eprosartan Impurity 2 suppliers
Eprosartan Impurity 2 manufacturers
Eprosartan Impurity 2 price
Order Eprosartan Impurity 2
Enquire Eprosartan Impurity 2
Eprosartan Impurity 2 cost
Eprosartan Impurity 2 Supplier
Eprosartan Impurity 2 Distributor
Eprosartan Impurity 2 for Method Validation
Eprosartan Reference Standard
Eprosartan Impurity 2 for ANDA Filing
Eprosartan Impurity 2 for Forced Degradation Studies
Eprosartan Impurity 2 Identification Standards
Eprosartan Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.